Balance Sheet (Annual)

FTK / Flotek Industries Inc. Balance Sheet shows account balances for the company at points in time. Balance Sheet data includes Assets, Current Assets, Fixed Assets, Property, Plant and Equipment (PPE), Inventory, Intangibles, Liabilities, Current Liabilities, Debt, Capital Lease Obligations, Common Stock, Retained Earnings, Treasury Stock, and Shareholders Equity.

All numbers are times 1,000 except per share units.

2011 2012 2013 2014 2015 2016 2017
Assets
  Assets Current
    Cash And Cash Equivalents At Carrying Value 46,682 2,700 2,730 1,266 2,208 4,823 4,584
    Accounts Receivable Net Current 44,567 42,259 65,016 78,624 49,197 47,152 46,018
    Inventory Net 37,888 45,177 63,132 85,958 85,492 58,283 75,759
    Income Taxes Receivable - - - - 4,700 12,752 2,826
    Assets Of Disposal Group Including Discontinued Operation Current - - - - - 43,900 0
    Other Assets Current 1,933 4,654 4,261 11,055 7,496 21,708 9,264
    Assets Current 132,061 96,214 137,661 179,599 151,742 188,670 138,451
  Property Plant And Equipment Net 43,914 56,499 79,114 86,111 91,913 74,691 73,833
  Goodwill 26,943 26,943 66,271 71,131 72,820 56,660 56,660
  Deferred Income Tax Assets Net - - - - - - 12,713
  Other Intangible Assets Net - 24,166 77,523 73,528 69,386 50,352 48,231
  Other Assets Noncurrent - - - - - - -
  Disposal Group Including Discontinued Operation Assets Noncurrent - - - - - 0 -
  Assets 232,012 219,867 375,581 423,276 403,090 386,588 329,888
Liabilities And Stockholders Equity
  Liabilities Current
    Accounts Payable Current 18,562 22,373 19,899 33,185 19,444 29,960 22,048
    Accrued Liabilities Current 8,397 6,503 12,778 12,314 12,894 12,170 14,589
    Interest Payable Current 2,097 114 111 93 111 24 43
    Long Term Debt Current - - 0 18,643 32,291 40,566 27,950
    Liabilities Current 33,699 41,931 62,564 65,542 67,003 91,054 64,630
  Deferred Income Tax Liabilities Net - - - - - - -
  Liabilities 153,714 65,137 125,829 116,922 109,081 98,887 64,630
  Commitments And Contingencies - - - - - - -
  Stockholders Equity
    Preferred Stock Value Outstanding - - 0 0 0 0 0
    Common Stock Value 5 5 6 5 6 6 6
    Additional Paid In Capital 166,814 195,485 266,122 254,233 273,451 318,392 336,067
    Accumulated Other Comprehensive Income Loss Net Of Tax - - -359 -502 -1,237 -956 -884
    Retained Earnings Accumulated Deficit -86,810 -37,019 -841 52,762 39,300 -9,830 -37,225
    Treasury Stock Value 1,667 3,701 15,176 495 17,869 20,269 33,064
    Stockholders Equity 78,298 154,730 249,752 306,003 293,651 287,343 264,900
    Minority Interest - - - 351 358 358 358
    Stockholders Equity Including Portion Attributable To Noncontrolling Interest - - - 306,354 294,009 287,701 265,258
  Liabilities And Stockholders Equity 232,012 219,867 375,581 423,276 403,090 386,588 329,888

Peers - Miscellaneous Chemical Products (289)

Related Articles

BLDP: Ballard Power Systems Analysis and Research Report

2018-08-13 - Asif

Core Business At Ballard, Ballard Power Systems is building a clean energy growth company. Ballard Power Systems is recognized as a world leader in proton exchange membrane (“PEM”) fuel cell power system development and commercialization. The company's principal business is the design, development, manufacture, sale and service of PEM fuel cell products for a variety of applications, focusing on its power product markets of Heavy-Duty Motive (consisting of bus, truck, rail and marine applications), Portable Power, Material Handling and Backup Power, as well as the delivery of Technology Solutions, including engineering services, technology transfer, and the license and sale of its extensive intellectual property portfolio and fundamental knowledge for a variety of fuel cell applications. A fuel cell is an environmentally clean electrochemical device that combines hydrogen fuel with oxygen (from the air) to produce electricity. The hydrogen fuel can be obtained from natural g...

MARA: Marathon Patent Group Analysis and Research Report

2018-08-13 - Asif

Overview Marathon Patent Group was incorporated in the State of Nevada on February 23, 2010 under the name Verve Ventures, Inc. On December 7, 2011, the company changed its name to American Strategic Minerals Corporation and were engaged in exploration and potential development of uranium and vanadium minerals business. In June 2012, the company discontinued its minerals business and began to invest in real estate properties in Southern California. In October 2012, the company discontinued its real estate business when its former CEO joined the firm and the company commenced its IP licensing operations, at which time the Company’s name was changed to Marathon Patent Group, Inc. On November 1, 2017, the company entered into a merger agreement with Global Bit Ventures, Inc. (“GBV”), which is focused on mining digital assets. Marathon Patent Group has since purchased its cryptocurrency mining machines and established a data center in Canada to mine digital assets. Following the me...

ECYT: Endocyte Analysis and Research Report

2018-08-13 - Asif

Business and Organization Endocyte, Inc. is a biopharmaceutical company and leader in developing targeted therapies for the treatment of cancer. The Company uses drug conjugation technology to create novel therapeutics and companion imaging agents for personalized targeted therapies. The agents actively target receptors that are over-expressed on diseased cells relative to healthy cells, such as prostate specific membrane antigen (“PSMA”) in prostate cancer. This targeted approach is designed to safely enable the delivery of highly potent drug payloads. The companion imaging agents are designed to identify patients whose disease over-expresses the target of the therapy and who are therefore more likely to benefit from treatment. In September 2017, the Company entered into a Development and License Agreement (the “License Agreement”) with ABX advanced biochemical compounds – Biomedizinische Forschungsreagenzien GmbH (“ABX”), pursuant to which the Company acquired exclusive ...

CUSIP: 343389102